Please login to the form below

Not currently logged in
Email:
Password:

Elenbecestat

This page shows the latest Elenbecestat news and features for those working in and with pharma, biotech and healthcare.

Germany’s Vivoryon raises €43m for Alzheimer’s drug trial

Germany’s Vivoryon raises €43m for Alzheimer’s drug trial

The announcement of aducanumab’s demise as well as the failure of AC Immune and Roche’s  crenezumab and other amyloid-targeting agents including Biogen/Eisai’s  elenbecestat and Amgen/Novartis’ 

Latest news

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics